AlphaCentric Advisors LLC acquires $1.16 million in Fulgent Genetics, Inc. (NASDAQ: FLGT)
AlphaCentric Advisors LLC has acquired a brand new stake in Fulgent Genetics, Inc. (Nasdaq: FLGT – Get the score) within the third quarter, in keeping with the newest 13F submitting with the Securities and Alternate Fee. The fund acquired 30,500 shares of the corporate’s inventory, with an estimated worth of $1,163,000. Fulgent Genetics makes up … Read more